Skip to content

Studying the body odor controlling efficacy of products

Evaluating Dermatological Safety and Malodor Control Efficacy of Test Products On Healthy Human Subjects Of Varied Skin Types

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013996
Enrollment
100
Registered
2018-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: BU-07: Baseline (T0), 4 hrs (T1), 6 hrs (T2), 8 hrs (T3), 24 hrs (T4)Dermatologists Visual Assessment of Axillary Skin for Irritation , Olfactory Panel Assessment, Subjects� Sel

Sponsors

ITC Life Science and Technology Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Equal distribution of gender (1:1) 2 Equal distribution of different skin types: Combination, Dry, Normal, Oily, Sensitive (As per modified Baumannââ?¬•s Skin Type questionnaire) 3 Age: 18 to 45 yrs 4 Volunteers in generally good health and not undergoing medical treatment 5 Volunteers without any cuts, marks and open wounds on both axillae 6 Volunteers free of any obvious infection of skin as determined by dermatologist 7 Volunteers with a malodor score above 2.5 on a scale of 0-5 with normal activity during the day with an odour difference of 8 Volunteers willing to give a written informed consent 9 Volunteers willing to abide by the study requirements and visit the site for regular follow up.

Exclusion criteria

Exclusion criteria: 1 Volunteers with known allergies or sensitivities to cosmetic products or its components like fragrances, preservatives etc 2 Volunteers who are currently undergoing / had undergone dermatological treatments or procedures within the last 1 month 3 Volunteers with pre-existing or dormant dermatologic conditions (e.g. psoriasis, rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with the study outcome as determined by the investigator 4 Volunteers with an extremely high ( >4.5) or extremely low ( 5 Volunteers with wide difference in malodor scores across right and left axillae ( >1). 6 Volunteers with scars which could interfere with expert grading 7 Volunteers who are nursing or pregnant (Self declaration / Urine pregnancy test) 8 Volunteers unwilling to abstain from alcohol consumption and smoking for the study duration 9 Volunteers viewed by the investigator as not being able to complete the study

Design outcomes

Primary

MeasureTime frame
To evaluate the dermatological safety and malodour control efficacy of the investigational productsTimepoint: Baseline (T0), 4 hrs (T1), 6 hrs (T2), 8 hrs (T3) and 24 hrs (T4)

Secondary

MeasureTime frame
malodour control efficacyTimepoint: Baseline (T0), 4 hrs (T1), 6 hrs (T2), 8 hrs (T3), 24 hrs (T4)

Countries

India

Contacts

Public ContactUma Ayachit

The KETs Scientific Research Centre, Cosmetology Division

uma@kelkarcosmetology.com25639644

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026